جستجو
   
    Delicious RSS ارسال به دوستان خروجی متنی
    کد خبر : 186775
    تاریخ انتشار : 26 تیر 1395 12:35
    تعداد بازدید : 520

    Journal of International Biotechnology Law

    Journal of International Biotechnology Law

    2004, Vol.1

    2005, Vol.2

    2006, Vol.3

    2007, Vol.4

    2008, Vol.5

    2009, Vol.6

     

    Journal of International Biotechnology Law, 2004, Vol.1

    Author

    Title

    number

    Page to Page

    Sven J.R. Bostyn

    Living in an (Imm) Material World: Bioinformatics and Intellectual Property Protection

    No.1, February

    pp. 2-10

    Roberto Andorno

    The Precautionary Principle: A New Legal Standard for a Technological Age

    No.1, February

    pp. 11-19

    Mark Perry

    Lifeform Patents: the high and the low

    No.1, February

    pp. 20-27

    Raymond O Rourke

    US- EU Trade War looming over GM Foods

    No.1, February

    pp. 28-31

    Kenneth J. Burchfiel

    The Written Description Requirement of U.S. Law as Applied to Biotechnology Inventions in Enzo Biochem

    No.1, February

    pp. 32-36

    Tor Butler-Cole

    News from the UK

    No.1, February

    pp. 37-39

    Joseph D. Ng

    DNA to protein and perspectives on protecting the fruits of structural genomic research

    No.1, February

    pp. 40-42

    Katja Rampelmann

    The Biotechnological Revolution, Scientific and Societal Aspects

    No.1, February

    pp. 43-44

    Masakazu Inaba, Darryl Macer

    Policy, Regulation and Attitudes towards Agricultural Biotechnology in Japan

    No.2, March

    pp. 45-53

    Sven J.R. Bostyn

    Living in an (Imm) Material World: Bioinformatics and Intellectual Property Protection (Part II)

    No.2, March

    pp. 54-61

    Rafael Capurro

    Ethics Between Law and Public Policy

    No.2, March

    pp. 62-66

    Angela Wasunna

    The Road to Biotechnology in Africa: A Question of Legal and Ethical Obstacles?

    No.2, March

    pp. 67-69

     

    International Declaration on Human Genetic Data

    No.2, March

    pp. 70-76

    R. R. Kishore

    Bioethics in India

    No.2, March

    pp. 77-80

    Ralf Greiner

    Methods for identification and quantification of genetically modified material in agricultural crops, processed food and animal feed in relation to regulatory requirements

    No.2, March

    pp. 81-85

    Nancy L. Jones, John F. Kilner

    Genetics, Biotechnology and the Future

    No.2, March

    pp. 86-88

    Florence Bellivier, Christine Noiville

    The commercialisation of human biomaterials: what are the rights of donors of biological material?

    No.3, May

    pp. 89-97

    Timothy Caulfield, Lorraine Sheremeta

    Biotechnology Patents and Embryonic Stem Cell Research: Emerging Issues (Part I)

    No.3, May

    pp. 98-104

    Mariko Nishizawa

    The current state and legal framework of preimplantation genetic diagnosis (PGD) in Japan

    No.3, May

    pp. 105-110

    Guido Westkamp

    Intellectual Property and Access to Genetic Material Copyright as an Alternative Form of Protection?

    No.3, May

    pp. 111-116

    Cosimo Marco Mazzoni

    Gift of Organs. What Kind of Gift?

    No.3, May

    pp. 117-121

    Henrique Moraes Prata

    Biosafety and access to genetic resources in Brazil- recent developments of the legislation

    No.3, May

    pp. 122-129

    W. J. Wall

    DNA analysis: Current status in court

    No.3, May

    pp. 130-132

    Valerie Normand

    Access to genetic resources and the fair and equitable sharing of benefits arising out of their utilization: developments under the Convention on Biological Diversity

    No.4, August

    pp. 133-141

    Timothy Caulfield, Lorraine Sheremeta

    Biotechnology Patents and Embryonic Stem Cell Research: Emerging Issues (Part II)

    No.4, August

    pp. 142-145

    Matthias Dau

    Biotechnology, Patents and the Need for a Fair Use Exception in U.S. Patent Law

    No.4, August

    pp. 146-152

    Carlos M. Correa

    Access to Genetic Resources and the FAO Treaty. The Case of Andean Countries

    No.4, August

    pp. 153-155

    Manuel Duval

    Intellectual property and genetic sequences: moving towards an integrated information system

    No.4, August

    pp. 156-160

    Erwin Bernat

    A Cause of Action for "Wrongful Birth" Under Austrian Tort Law: Don t Take the Civil Code too Seriously!

    No.4, August

    pp. 161-165

    Kerstin Stieber Roger

    The Social Impact of Gender and Culture on Decision- Making in Genetic Testing

    No.4, August

    pp. 166-173

    Stefan Dimitrov, Thijs Etty, Marjan Oomens, Han Somsen

    Regulating Biotechnology

    No.4, August

    pp. 174-176

    Laura J. Loppacher, William A. Kerr

    China's Biotechnology Industry and the International Protection of Intellectual Property Rights

    No.5, September

    pp. 177-186

    Anthony Mark Cutter, Sarah Wilson, Ruth Chadwick

    Balancing Powers: Examining models of Biobank Governance

    No.5, September

    pp. 187-192

    Niu Huei-Chih

    Remedies for Injured Human Subject in the Age of Modern Biotechnology- A Perspective on Taiwan s Civil Law and Health Regulations

    No.5, September

    pp. 193-199

    Lydia Zepeda

    Food Sovereignty or Trade Obstruction? Labelling of Genetically Engineered Foods

    No.5, September

    pp. 200-204

    Rajkumar Dubey

    Biotechnology- Destination India

    No.5, September

    pp. 205-209

    Berna Arda

    Ethical respects of biotechnology and the case of Turkey

    No.5, September

    pp. 210-213

    Hong Xue

    Human Genetic Resources, Biopiracy and China s Response: A Case Study of Harvard- Affiliated Human Genetic Projects in China s Anhui Province (Part I)

    No.2, September

    pp. 214-220

    Sara Boettiger, Dan L. Burk

    Open Source Patenting

    No.6, December

    pp. 221-231

    Mark Mansour

    The EU's Traceability and Labeling and Food and Feed Proposals for Products of Transgenic Origin

    No.6, December

    pp. 232-238

    Peter-Tobias Stoll

    The FAO Seed Treaty - New International Rules for the Conservation and Sustainable Use of Plant Genetic Resources for Food and Agriculture

    No.6, December

    pp. 239-243

    Graham Brookes

    Co- existence of GM and non GM crops: real world experience shows it is not a problem

    No.6, December

    pp. 244-246

    Tade M. Spranger

    Patentability of Stem Cell Inventions with Special Emphasis to EC Law

    No.6, December

    pp. 247-254

    Cornelia Alboiu

    Romania enforces biotech legislation and complies with the EU directive on biotech

    No.6, December

    pp. 255-257

    Hong Xue

    Human Genetic Resources, Biopiracy and China s Response: A Case Study of Harvard- Affiliated Human Genetic Projects in China s Anhui Province (Part II)

    No.6, December

    pp. 258-264

    Journal of International Biotechnology Law, 2005, Vol.2

    Author

    Title

    number

    Page to Page

    Richard Twine

    From Warnock to the Stem Cell Bank- Evaluating the UK s Regulatory Measures for Stem Cell Research

    No.1, January

    pp. 1-14

    Muriel Lightbourne

    The FAO Treaty on Plant Genetic Resources: Do All Roads Lead to Rome?

    No.1, January

    pp. 15-24

    Motomu Shimoda

    Risk Assessment in Advanced Biomedical Technology

    No.1, January

    pp. 25-29

    Patricia Madrigal Cordero, Vivienne Solis Rivera

    Some Reflections on Legal Regulations on Biotechnology in Costa Rica

    No.1, January

    pp. 30-33

    Osamu Kanamori

    Cultural Attendance on Homo Geneticus

    No.1, January

    pp. 34-40

    Martin Heyer

    Report on the 2nd International Meeting of the Stem Cell Network North Rhine Westphalia

    No.1, January

    pp. 41-44

    Mark Henaghan, Dana Wensley

    Preimplantation Genetic Diagnosis: A Discussion of Regulatory Mechanisms of Control from a New Zealand Perspective

    No.2, March

    pp. 45-53

    Laura J. Loppacher

    The Conflicting International Trade Law Governing Products of Biotechnology: The Case of Biofuels

    No.2, March

    pp. 54-61

    Luigi Palombi

    The Impact of TRIPS on the Validity of the European Biotechnology Directive

    No.2, March

    pp. 62-70

    Henrique Moraes Prata

    Regulation of Assisted Reproduction Techniques in Brazil

    No.2, March

    pp. 71-74

    Stefan Kohler

    Country Report Switzerland: Getting the Legal System ready for Biotechnology

    No.2, March

    pp. 75-82

    Emilio Mordini

    Conclusions of the International Conference on Ethical Implications of Research into the Prevention of Bioterrorism

    No.2, March

    pp. 83-87

    Matthias Herdegen

    The Coexistence of Genetically Modified Crops with Other Forms of Farming: The Regulation by EU Member States in the Light of EC Law

    No.3, May

    pp. 89-98

    Margaret Otlowski

    Use of Genetic Test Information in Life Insurance: An Evaluation of Different Regulatory Models

    No.3, May

    pp. 99-104

    William A. Kerr, Grant E. Isaac

    The International Treatment of Biological Material as Intellectual Property

    No.3, May

    pp. 105-111

    Simon Brown, Daud Hassan

    Application of the Precautionary Principle in the 2000 Biosafety Protocol to the 1992 Convention on Biological Diversity

    No.3, May

    pp. 112-116

    Bernd van der Meulen

    The new EU regulatory framework for GM food (Part I) Procedural aspects: safety assessment, authorisation and administrative review

    No.3, May

    pp. 117-122

    Karinne Ludlow

    Regulation on Agricultural Genetically Modified Organisms in Australia

    No.3, May

    pp. 123-129

    Sarah E. Hilmer

    Biotechnology Law in The Socialist Republic of Vietnam

    No.3, May

    pp. 130-132

    Roberto Andorno

    The Oviedo Convention: A European Legal Framework at the Intersection of Human Rights and Health Law

    No.4, July

    pp. 133-143

    Cary Fowler

    Heavy Burden: Promoting Public Policy through the Use of Material Transfer Agreements for Plant Genetic Resources

    No.4, July

    pp. 144-149

    W. Bradnee Chambers, Alphonse Kambu

    Mohammed and the Mountain: The Sui Generis Debate on Traditional Knowledge

    No.4, July

    pp. 150-154

    Tade Matthias Spranger

    Queensland's Biodiscovery Act 2004

    No.4, July

    pp. 155-157

    Bernd van der Meulen

    The new EU regulatory framework for GM food (Part II) Traceability, labelling and enforcement

    No.4, July

    pp. 158-162

    Grace Li

    Euthanasia, a Matrix of Cure or Exacerbation: A Legal Perspective of Current Bioethics Issue in China

    No.4, July

    pp. 166-173

    Christina Hirche

    Gene- Genome- Systems Biology: Engineering know- how in greater demand than ever

    No.4, July

    pp. 174-176

    Glen Kurokawa, Darryl Macer

    Biosafety Regulation Trends in Southern and Southeastern Asia

    No.5, September

    pp. 177-184

    Sarah E. Hilmer

    Property in a human body: a common law approach

    No.5, September

    pp. 185-189

    Niclas Kunczik

    The german way of dealing with "The Tragedy of the anticommons": purpose- bound protection for product patents on genetic information in Germany

    No.5, September

    pp. 194-197

    Bindu Dey

    Pharmacogenomics and Data Protection

    No.5, September

    pp. 198-200

     

    European Commision: Development and Implications of Patent Law in the Field of Biotechnology and Genetic Engineering

    No.5, September

    pp. 201-204

     

    European Commission: Life Sciences and Biotechnology: A Strategy for Europe Third Progress Report and Future Orientations

    No.5, September

    pp. 205-210

     

    United Nations: Declaration on Human Cloning

    No.5, September

    pp. 211-211

    Xinqing Zhang

    Gene Therapy in PR China: Regulations and Ethical Concerns

    No.5, September

    pp. 212-216

    Carsten Thoms, Peter Schupp

    Biotechnological potential of marine sponges and their associated bacteria as producers of new pharmaceuticals (Part I)

    No.5, September

    pp. 217-220

    Victoria Jimenez, Dennis Fernandez

    Intellectual Property and Biotechnology

    No.6, November

    pp. 221-244

    Sam Blay

    International Regulation of Biotechnology: Problems and Prospects

    No.6, November

    pp. 245-251

    Eduardo A. Rueda

    Group- Differentiated Rights and Informed Consent for Indigenous Group-Based Genetic Research

    No.6, November

    pp. 252-256

    Carsten Thoms, Peter Schupp

    Biotechnological potential of marine sponges and their associated bacteria as producers of new pharmaceuticals (Part II)

    No.6, November

    pp. 257-264

    Journal of International Biotechnology Law, 2006, Vol.3

    Author

    Title

    number

    Page to Page

    Will Rosellini, Frank McEachern

    The United States Database Debate: Proteins as virtual property

    No.1, January

    pp. 1-11

    Maria Cristina Rosamond Pinto

    Abortions- History and Facts

    No.1, January

    pp. 12-15

    Bradley J. Olson

    The Supreme Court's Merck KGaA v. Integra Lifesciences I, LTD. Opinion extends the Exemption from Infringement under Section 271 (e) (1) to Biotechnology "Research Tools"

    No.1, January

    pp. 16-24

    Jochen Taupitz

    The Use of Human Bodily Substances and Personal Data for Research: The German National Ethics Council s Opinion

    No.1, January

    pp. 25-32

    Kartina A. Choong

    Informed Consent and Psychotherapy: The Travails of Consistency (Part I)

    No.1, January

    pp. 33-44

    Der-Chin Horng

    Biotechnology and the WTO: A Review of some Selective Issues

    No.2, March

    pp. 45-56

    Niall Scott

    Conditions, Preferences and Race in Organ Donation

    No.2, March

    pp. 57-62

    Hans-Georg Dederer

    Regulation of Human Embryonic Stem Cell Research in Germany

    No.2, March

    pp. 63-71

    Shun-liang Hsu

    The Paradox Facing DNA Patenting in Europe

    No.2, March

    pp. 72-83

    Kartina A. Choong

    Informed Consent and Psychotherapy: The Travails of Consistency (Part II)

    No.2, March

    pp. 84-88

    Dianne Nicol

    Public Trust, Intellectual Property and Human Genetic Databanks: The Need to Take Benefit Sharing Seriously

    No.3, May

    pp. 89-103

    Cosimo Marco Mazzoni

    Real Protection for the Embryo

    No.3, May

    pp. 104-111

    John A. Tessensohn, Shusaku Yamamoto

    Recent Landmark Changes in Japanese Biotechnology and University Patenting (Part I)

    No.3, May

    pp. 112-115

    Mohamed Salem Abou El Farag Balat

    Intellectual Property Rights and Plant Varieties Protection in Egypt: The new Sui Generis Regime, Public Interest and the TRIPs Agreement

    No.3, May

    pp. 116-132

    Sarah E. Hilmer

    The Usage of Alternative Dispute Resolution Mechanisms in the Field of Biotechnology

    No.4, July

    pp. 133-149

    Tade Matthias Spranger

    Indonesia's Regulation on the Biosafety of Genetically Engineered Products

    No.4, July

    pp. 150-151

    John A. Tessensohn, Shusaku Yamamoto

    Recent Landmark Changes in Japanese Biotechnology and University Patenting (Part II)

    No.4, July

    pp. 152-159

    Sufian Jusoh

    Developing Biotechnology Legal Systems in Developing Countries: The Case for Malaysia (Part I)

    No.4, July

    pp. 160-172

    Christina Hirche, Charles Butcher

    Bioprocessing: Engineering Know- How in Greater Demand than Ever

    No.4, July

    pp. 173-176

    Matthew Rimmer

    Miami Heat: Patent Law, Informed Consent and Benefit-Sharing

    No.5, September

    pp. 177-191

    Chamundeeswari Kuppuswamy

    Cloning: National and International Law

    No.5, September

    pp. 192-208

    Sufian Jusoh

    Developing Biotechnology Legal Systems in Developing Countries: The Case for Malaysia (Part II)

    No.5, September

    pp. 209-217

     

    The World Medical Association Statement on Genetics and Medicine

    No.5, September

    pp. 218-220

    Don Chalmers

    Ethical Principles for Research Governance of Biobanks

    No.6, November

    pp. 221-230

    Konrad Lachmayer

    Legal aspects of "black biotechnology": Counter- terrorism between prevention and use of biotechnological products

    No.6, November

    pp. 231-236

    Manuel Ruiz

    Genetic resources, biotechnology and intellectual property: the current debate and developing a constructive agenda for the South

    No.6, November

    pp. 237-243

    Julia Targiel

    Commercialisation of Human Bodily Substances and Human Genetic Information within the Area of Bio- and Tissue- Banks with special Emphasis to Estonia, Iceland, the UK und Germany

    No.6, November

    pp. 244-264

    Journal of International Biotechnology Law, 2007, Vol.4

    Author

    Title

    number

    Page to Page

    Catherine Rhodes

    Four Key Roles for Regulation of Biotechnology: Are They Being Fulfilled at the International Level?

    No.1, January

    pp. 1-11

    Takis Vidalis

    Regulating Assisted Reproduction in the EU: Time for a new Directive?

    No.1, January

    pp. 12-15

    Heide Muckenfuss, Klaus Cichutek, Egbert Flory

    Current Regulation of Advanced Therapy Medicinal Products in the European Union

    No.1, January

    pp. 16-19

     

    The UNCTAD BioTrade Initiative and the CBD

    No.1, January

    pp. 20-20

    Jasmina Mutabzija, Ivana Kunda

    Legal Limitations on Genetic Research and the Commercialisation of its Results in the Republic of Croatia

    No.1, January

    pp. 21-34

    Michael Fuchs, Martin Heyer, Alexander Berbuir

    From ethical advice to legal regulation: History and practise of Research Ethics Committees in Germany

    No.1, January

    pp. 35-44

    Han Aera

    The Ethical and Regulatory Problems in the Stem Cell Scandal

    No.2, March

    pp. 45-68

    Timothy Caulfield, Russell Brown, Eric M. Meslin

    Challenging a Well Established Consent Norm?: One Time Consent for Biobank Research

    No.2, March

    pp. 69-74

    Susanne Beck

    Enhancement as a Legal Challenge

    No.2, March

    pp. 75-81

    Sarah E. Hilmer

    Biotechnology Investment in Vietnam

    No.2, March

    pp. 82-88

    Benjamin Capps, Alastair V. Campbell

    Why (only some) Compensation for Oocyte Donation for Research Makes Ethical Sense

    No.3, June

    pp. 89-102

    Eiko Suda, Darryl Macer

    Policy and Attitudes towards Collection of Personal DNA in genetic databases in Japan

    No.3, June

    pp. 103-110

    Nuria Terribas

    New Spanish legislation for biomedical research

    No.3, June

    pp. 111-112

     

    Opinion on the ethical aspects of nanomedicine: Legal Aspects

    No.3, June

    pp. 113-126

    Gunter Festel

    Biotechnology in China

    No.3, June

    pp. 127-130

    Luc Michel

    Moral issues of surgical emergencies

    No.3, June

    pp. 131-132

    Minakshi Bhardwaj

    Biobanks, association studies and validity: ethical, legal and social challenges in Asia

    No.4, July

    pp. 133-145

    Jiao Hongtao, Luo Min

    The Rights Design and Institution Arrangement of Genetic Testing Technology: With Analysis on Legalization of Chinese Bioethics in Bioethics Globalization

    No.4, July

    pp. 146-160

     

    Genetic Privacy and Non- discrimination Bill

    No.4, July

    pp. 161-165

    Negar Tayyar

    Biotechnology Regulations in the Islamic Republic of Iran

    No.4, July

    pp. 166-176

    Gregor Wolbring

    Bio- tech, NanoBio- Tech, SynBio-tech, NanoSynBio- tech? The changing face of biotech law? (Part I)

    No.5, September

    pp. 177-186

    Sarah J.L. Edwards, Stephen Guest

    Vulnerable Adults in Research: From Consent to Assent?

    No.5, September

    pp. 187-197

    Claudia Mund

    Biobanks and Legislation in Switzerland- a data protection perspective

    No.5, September

    pp. 198-209

    Swiss Academy of Medical Sciences

    Biobanks: Obtainment, preservation and utilisation of human biological material- Medical- ethical guidelines and recommendations

    No.5, September

    pp. 210-214

    Marilia Bernardes Marques

    Ethical debates in Brazil concerning potential medical applications of embryonic stem cells

    No.5, September

    pp. 215-220

    Gregor Wolbring

    Bio- tech, NanoBio- Tech, SynBio-tech, NanoSynBio- tech? The changing face of biotech law? (Part II)

    No.6, December

    pp. 221-226

    Karla Schneider, Cristoph Merkle

    "Minority Report"- Fiction or Reality? Legal questions raised by neuroscience with particular emphasis on German criminal law

    No.6, December

    pp. 227-232

    Sarah E. Hilmer

    Australia's (NSW) recent legislative developments of Human Cloning, Other Prohibited Practices and Research Involving Human Embryos

    No.6, December

    pp. 233-238

    Andy Miah

    Genetic Selection for Enhanced Health Characteristics

    No.6, December

    pp. 239-264

    Journal of International Biotechnology Law, 2008, Vol.5

    Author

    Title

    number

    Page to Page

    Mohamed Salem Abou El Farag

    TRIPs, TRIPs- PLUS, Developing Countries and Public Health: The Case of Egypt

    No.1, January

    pp. 1-15

    Janne Rothmar Herrmann

    Are You a Man or a Mouse?

    No.1, January

    pp. 16-19

    Sharon Levy

    Take three cases: A reflection on the mission of applying law to human frailty

    No.1, January

    pp. 20-24

    Bradley J. Olson

    Post- Merck KGaA v. Integra, A Negative Impact On Research Tools ?

    No.1, January

    pp. 25-33

    Ying Zhan

    Patent Protection for Biotechnology in China: the Current Legislation and the Proposed Third Amendment

    No.1, January

    pp. 35-36

    Margaret Otlowski

    Australian Developments With Regard To Regulation of Embryonic Stem Cell Research and Therapeutic Human Cloning

    No.1, January

    pp. 37-44

    Nils Fischer

    National Bioethics Committees in selected States of North Africa and the Middle East

    No.2, April

    pp. 45-58

    Zhu Xuezhong, Zhou Yongtao, Tang Jie

    The Progress of Chinese Legal Protection in Genetic Resources

    No.2, April

    pp. 59-63

    Parliament of the Republic of India

    DNA PROFILING BILL 2007

    No.2, April

    pp. 64-78

    Gunter Festel

    Development of the Pharma and Biotech Industry in India with Focus on RandD Activities

    No.2, April

    pp. 79-81

    Michal-Ruth Schweiger, Hans Lehrach

    From bench to bedside: New technologies for cancer diagnosis and treatment

    No.2, April

    pp. 82-84

    Stephan Schleim

    The Brain on the Stand? Interactions Between Neuroscience, Ethics and Law

    No.2, April

    pp. 85-88

    Jochen Taupitz

    The Chimbrids project of the universities of Heidelberg and Mannheim

    No.3, June

    pp. 89-101

     

    Cologne Paper: Bright future for biotechnology

    No.3, June

    pp. 102-102

    Yoshihiro Okada, Kazuo N. Watanabe

    Rationalization of the Gene as a Corporate Stakeholder Based on International Laws

    No.3, June

    pp. 103-112

    Chang Junli, Zhu Xuezhong, He Guangyuan

    Chinese Law System of Intellectual Property Right Protection in Biotechnology

    No.3, June

    pp. 113-117

    German Precidency of the Council of the European Union

    En Route to the Knowledge- Based Bio- Economy

    No.3, June

    pp. 118-132

    Sarah E. Hilmer

    Arbitration Clauses in biotechnology related contracts from a Hong Kong institutional perspective

    No.4, August

    pp. 133-142

    Margaret Otlowski

    Key Themes in the Policy Debate on Human Genetic Research and Genetic Databanks: An Evaluation

    No.4, August

    pp. 143-152

    Tang Chun, Zhu Xuezhong

    Intellectual Property Right Protection for Biomedicines in China

    No.4, August

    pp. 153-157

    Jack Price, Will Rosellini

    Neuroprosthetics and Medicare Reimbursement

    No.4, August

    pp. 158-163

    Congress of the United States of America

    Genetic Information Nondiscrimination Act of 2008 (Part I) (Enrolled as Agreed to or Passed by Both House and Senate)

    No.4, August

    pp. 164-169

    Aphra Green, Mark Henaghan, Richman Wee

    The introduction of a statutory experimental use exemption in New Zealand: evidence of a need for change

    No.4, August

    pp. 170-174

    Donald Chalmers

    The Regulation of Embryo and Stem Cell Research in Australia: Licensing with a Restrictive Tilt

    No.5, October

    pp. 177-185

    Ubaka Ogbogu, Peter Rugg-Gunn

    The legal status of novel stem cell technologies in Canada

    No.5, October

    pp. 186-199

    Mathew Rimmer

    Vanquishing the "Patent Trolls"

    No.5, October

    pp. 200-202

    Congress of the United States of America

    Genetic Information Nondiscrimination Act of 2008 (Part II) (Enrolled as Agreed to or Passed by Both House and Senate)

    No.5, October

    pp. 203-210

    Filip Krepelka

    European Union and Controversial Biotechnologies- Technology, Economy, Ethics, Politics and Law in United Europe

    No.5, October

    pp. 211-220

    Margaret Sleeboom-Faulkner, Prasanna Kumar Patra

    The Bioethical Vacuum: national policies on human embryonic stem cell research in India and China

    No.6, November

    pp. 221-234

    Bradley J. Olson

    Biomedical and Biotechnology Licensing Issues after MedImmune

    No.6, November

    pp. 235-240

    Janne Rothmar Herrmann, Malene Rowlandson

    The Role of Ethics and Morality in EU Law

    No.6, November

    pp. 241-251

    Shun-Liang Hsu

    Patient- Centred Research Medical Ethics

    No.6, November

    pp. 252-258

    Niall Scott

    More Altruism, Please

    No.6, November

    pp. 259-264

    Journal of International Biotechnology Law, 2009, Vol.6

    Author

    Title

    number

    Page to Page

    Amedeo Santosuosso

    The Worldwide Law- Making Process in the Field of Science and Law: A Laboratory Bench (IBLARC)

    No.1, February

    pp. 1-11

    Maria Graciela de Ortuzar

    Toward a Legal- Ethical Framework for Regulating Human Genetic Information in Vulnerable Populations: An Issue of Justice

    No.1, February

    pp. 12-19

    Henning Wegmann

    Informed Consent- Essential Contents and Consequences of Violation

    No.1, February

    pp. 20-28

    Sosuke Iwae

    Attitude toward Public Trust; the Discourses of Accountability and Transparency in Biobank Japan

    No.1, February

    pp. 29-34

    Mohammad Reza Parvin

    Legal and Biological Perspectives of "Plant Variety" in IPR Context

    No.1, February

    pp. 35-40

    Ole Doring

    Probing the Trial of Medical Trials: Chinese- European Collaborations; A Conference Report

    No.1, February

    pp. 41-44

    Hui-Chih Chen, Kuei-Jung Ni

    An Analysis of the WTO Panel Ruling on GMOs Disputes: Focusing on the Interpretation and Application of Articles 2.2, 5.1 and 5.7 of the SPS Agreement

    No.2, April

    pp. 45-60

    Ann Bruce, Shawn H.E. Harmon

    Discursive Typologies and Moral Values in Stem Cell Politics, Regulation and Commercialisation: Some Preliminary Observations (Part I)

    No.2, April

    pp. 61-66

    Christina Pinsdorf

    Germ Line Gene Transmission in Prenatal Gene Therapy- An Approach to Ethical Judgement

    No.2, April

    pp. 67-72

    World Medical Association

    Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects

    No.2, April

    pp. 73-76

    John A. Tessensohn, Shusaku Yamamoto

    Accelerated Examination and Grant of Japanese Biotechnology Patents

    No.2, April

    pp. 77-88

    Qiao Yongzhong, Zhu Xuezhong

    Patent Protection of the Traditional Chinese Medicine and Its Impact on the Related Industries in China

    No.3, June

    pp. 99-108

    Ida Madieha Azmi

    The Gap between the Legal and Regulatory Framework of Health and Medical Biotech Research and Development in Malaysia and the Needs of the R and D Institutes in Malaysia

    No.3, June

    pp. 109-121

    Darryl Macer

    Efforts to Overcome Sex Selection in Reproduction in Asia

    No.3, June

    pp. 122-132

    Darryl Gunson

    Cognitive Enhancement, Analogical Reasoning and Social Justice

    No.4, July

    pp. 133-149

    Yutaka Kato

    Elaborating the List of Nanotech- related Ethical Issues

    No.4, July

    pp. 150-155

    Parliament of Kenya

    The Biosafty Act

    No.4, July

    pp. 156-167

    Nils Fischer

    Egypt's draft laws on organ transplantation

    No.4, July

    pp. 158-172

    Henning Wegmann

    The "new" Declaration of Helsinki

    No.4, July

    pp. 173-176

    Catherine Rhodes

    Is the International Regulation of Biotechnology Coherent?

    No.5, September

    pp. 177-191

    Gregor Wolbring

    'Therapeutic', enhancement enabling, assistive devices and the UN Convention on the rights of persons with disabilities: A missing lens in the enhancement regulation discourse

    No.5, September

    pp. 192-203

    Katherine Drabiak-Syed

    Revisiting the USPTO s Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy

    No.5, September

    pp. 204-209

    Marilia Bernardes Marques

    Pandemic Diseases: Pharmaceutical Drugs and Vaccines Accessibility in Brazil

    No.5, September

    pp. 210-215

    Cristina Pinto

    The growing role of genetic professionals in forensic DNA

    No.5, September

    pp. 216-220

    Takis Vidalis

    Meeting Darwin: The Gradual Emergence of Biolaw

    No.6, November

    pp. 221-227

    Tade M. Spranger

    Legal Implications in Connection with the Generation and Usage of Neuro-Scientific Findings

    No.6, November

    pp. 228-234

    Nils Fischer

    Embryo research in the Middle East

    No.6, November

    pp. 235-241

    The Socialist Republic of Vietnam

    Biodiversity Law

    No.6, November

    pp. 242-261

    Ciara Toole, Christen Rachul

    The Age of Personalized Genomics

    No.6, November

    pp. 262-263

    DECHEMA

    Dialogue of Disciplines: ProcessNet and Biotechnologists Meet in Mannheim

    No.6, November

    pp. 264-264

     


    نظر شما



    نمایش غیر عمومی
    تصویر امنیتی :
تعداد بازدید کنندگان کل :
تا کنون :
27662293
اکنون :
19